Archives
Expert Consensus: Exercise for Neuropathic Pain.
16 Feb, 2022 | 08:25h | UTCExercise for Neuropathic Pain: A Systematic Review and Expert Consensus – Frontiers in Medicine
Cost-effectiveness of physical therapy vs. intra-articular glucocorticoid injection for knee osteoarthritis: a secondary analysis from a randomized clinical trial.
16 Feb, 2022 | 08:24h | UTC
Cohort Study: Association between handover of anesthesiology care and 1-year mortality among adults undergoing cardiac surgery.
16 Feb, 2022 | 08:20h | UTCInvited Commentary: Safety of Complete Anesthesia Handovers in the Cardiac Surgical Patient – JAMA Network Open
Commentary on Twitter
Anesthesia handover was associated with a higher risk of death at 30 days and 1-year and increased resource utilization. Strategies are needed to balance provider well-being and adverse impact of physician fatigue with unintended info loss during handover. https://t.co/yqQEwH0ksx
— JAMA Network Open (@JAMANetworkOpen) February 11, 2022
Perspective: Providing compassionate care in the intensive care unit.
16 Feb, 2022 | 08:19h | UTC
Digital interventions in mental health: evidence syntheses and economic modelling.
16 Feb, 2022 | 08:21h | UTC
Cohort Study: Multiple sclerosis disease activity and disability following discontinuation of Natalizumab for pregnancy.
16 Feb, 2022 | 08:22h | UTC
ACR Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric COVID-19.
15 Feb, 2022 | 10:17h | UTCCommentary and summary: ACR Updates Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With COVID – RheumNow
Why don’t most people with COVID need to test for another 30 days, even if they’re re-exposed?
15 Feb, 2022 | 10:14h | UTC
Essay: Tuberculosis in times of COVID-19.
15 Feb, 2022 | 10:16h | UTCTuberculosis in times of COVID-19 – Journal of Epidemiology & Community Health
Related:
Covid-19’s Devastating Effect on Tuberculosis Care — A Path to Recovery.
Global tuberculosis progress reversed by COVID-19 pandemic.
How COVID is derailing the fight against HIV, TB and malaria.
How COVID hurt the fight against other dangerous diseases
World TB Day | Report: COVID-19 Eliminates Twelve Years of Progress Against Tuberculosis
Tuberculosis and Covid-19: Fighting a deadly syndemic
Omicron-targeted vaccines do no better than original jabs in early tests in animals.
15 Feb, 2022 | 10:09h | UTCOmicron-targeted vaccines do no better than original jabs in early tests – Nature
Retrospective Cohort: Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications.
15 Feb, 2022 | 10:11h | UTCNews Release: NIH-funded study suggests COVID-19 increases risk of pregnancy complications – NIH News Releases
Commentary on Twitter
In this study, among pregnant and postpartum individuals, #SARSCoV2 infection was associated with increased risk of a composite outcome of maternal mortality or serious morbidity from obstetric complications. https://t.co/51wcT8GhJq
— JAMA (@JAMA_current) February 7, 2022
Scientists deliberately gave people COVID — here’s what they learnt.
15 Feb, 2022 | 10:06h | UTCScientists deliberately gave people COVID — here’s what they learnt – Nature
Original Study: [Preprint] Results from the first Covid-19 human challenge study (deliberately infecting individuals in a controlled environment).
Related:
World’s first coronavirus “Human Challenge” study receives ethics approval in the UK (several texts on the subject)
Meta-analysis of randomized clinical trials: vaccines to prevent COVID-19.
15 Feb, 2022 | 10:04h | UTC
Systematic Review: Efficacy of antiviral therapies for COVID-19.
15 Feb, 2022 | 10:02h | UTC
Study identifies risk factors for severe CoviD-19 in children.
15 Feb, 2022 | 10:01h | UTCRisk Factors for Severe COVID-19 in Children – Pediatrics
APASL clinical practice guidance: the diagnosis and management of patients with primary biliary cholangitis.
15 Feb, 2022 | 09:56h | UTCRelated:
A consensus integrated care pathway for patients with primary biliary cholangitis.
Biliary Endoscopy in the Management of Primary Sclerosing Cholangitis and its Complications
Covid-19: Fourth vaccine doses—who needs them and why?
15 Feb, 2022 | 09:59h | UTCCovid-19: Fourth vaccine doses—who needs them and why? – The BMJ
Rickets guidance: part I—diagnostic workup.
15 Feb, 2022 | 09:51h | UTCRickets guidance: part I—diagnostic workup – Pediatric Nephrology
EAACI Position Paper: Hypersensitivity reactions to chemotherapy.
15 Feb, 2022 | 09:54h | UTCHypersensitivity reactions to chemotherapy: an EAACI Position Paper – Allergy
M-A: In patients undergoing colorectal surgery with pelvic dissection, removing urinary catheters on postoperative days 3–4 may provide a balance, minimizing the risk of urine retention (increased when taken too soon) and urinary tract infections (increased when taken too late).
15 Feb, 2022 | 09:45h | UTC
RCT: A supraclavicular ultrasound-guided right subclavian venous catheterization approach was non-inferior in terms of safety compared to an ultrasound-guided infraclavicular approach.
15 Feb, 2022 | 09:46h | UTCSupraclavicular versus infraclavicular approach for ultrasound-guided right subclavian venous catheterisation: a randomised controlled non-inferiority trial – Anaesthesia (link to abstract – $ for full-text)
Systematic Review: Electrocardiographic features of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction.
15 Feb, 2022 | 09:47h | UTC
M-A: Timing of carotid intervention in symptomatic carotid artery stenosis.
15 Feb, 2022 | 08:51h | UTC
A practical guide to the evaluation of small bowel bleeding.
15 Feb, 2022 | 09:49h | UTCA Practical Guide to the Evaluation of Small Bowel Bleeding – Mayo Clinic Proceedings
Cluster Randomized Clinical Trial: An electronic decision support system for deprescribing in hospitalized older adults was safe and led to improvements in deprescribing but did not reduce adverse drug events.
15 Feb, 2022 | 09:43h | UTC
Commentary on Twitter
Randomized control trial found that @MedSaferTool increases #deprescribing by 22% at hospital discharge but little impact on short term adverse drug events. https://t.co/XqiSwFSPEz @DrEmilyMcD @DrToddLee @DeprescribeUS
— JAMA Internal Medicine (@JAMAInternalMed) January 18, 2022